SRx Health Allocates Over 10% Capital to Astro SPV Backing SpaceX and AI
SRXH•SRx Health Solutions has invested more than 10% of its investable capital in Astro Investment XVII, an SPV affiliated with Astro Capital and tied to EMJ Crypto Technologies. The SPV holds stakes in SpaceX and other AI and space companies, reflecting the company’s push into high-growth technology sectors.
1. Investment Details
SRx Health Solutions allocated over 10% of its investable capital to Astro Investment XVII, a special purpose vehicle affiliated with Astro Capital and EMJ Crypto Technologies. The SPV’s portfolio includes stakes in SpaceX along with other leading artificial intelligence and space firms.
2. Strategic Rationale
Board member Michael Young said the investment demonstrates belief in the long-term value of both AI and space sectors. By partnering with professional managers at Astro Capital and EMJ Crypto, SRx Health aims to capture high-growth opportunities.
3. Merger and Filings
This investment coincides with SRx Health’s definitive merger agreement with EMJ Crypto Technologies and the filing of a Form S-4 registration statement to register shares for the proposed transaction. Key upcoming milestones include SEC effectiveness and a shareholder vote.
4. Next Steps
Once the registration statement is declared effective, the definitive prospectus will be sent to stockholders for review. Investors should examine the Form S-4 for full transaction terms, related risks and timeline for closing.
